InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Olema Pharmaceuticals, Inc.

OLMA Clue Score20
United States Fiscal year ends December CIK 0001750284 Results filed 10 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

65
Insider
Date
Role
Action
Shares
Price
Amount
Cyrus Harmon
24 Jul 2026
Director
Sell
12,500
$11.71
$146.43K
Cyrus Harmon
23 Jul 2026
Director
Sell
12,500
$11.58
$144.74K
Cyrus Harmon
20 Jan 2026
Director
Sell
10,000
$26.88
$268.80K
Shane William Charles Kovacs
15 Jan 2026
Ch. Operating & Financial Off.
Sell
100,000
$28.73
$2.87M
Cyrus Harmon
14 Jan 2026
Director
Sell
3,489
$29.12
$101.60K
Shane William Charles Kovacs
13 Jan 2026
Ch. Operating & Financial Off.
Sell
3,822
$28.01
$107.05K
David C. Myles
12 Jan 2026
Ch. Discov. & Non-Clin Dev Off
Sell indirect
10,000
$28.34
$283.40K
Cyrus Harmon
22 Dec 2025
Director
Sell
2,881
$28.53
$82.19K
David C. Myles
19 Dec 2025
Ch. Discov. & Non-Clin Dev Off
Sell
6,046
$31.39
$189.78K
David C. Myles
19 Dec 2025
Ch. Discov. & Non-Clin Dev Off
Sell
43,729
$30.40
$1.33M
David C. Myles
19 Dec 2025
Ch. Discov. & Non-Clin Dev Off
Sell
1,225
$28.08
$34.40K
Cyrus Harmon
18 Sep 2025
Director
Sell indirect
3,086
$8.32
$25.68K
Cyrus Harmon
18 Sep 2025
Director
Sell
10,000
$8.33
$83.30K
Cyrus Harmon
16 Sep 2025
Director
Sell indirect
1,914
$8.08
$15.47K
Cyrus Harmon
16 Sep 2025
Director
Sell
10,000
$8.04
$80.40K
G. Walmsley Graham
17 Dec 2024
Director
Sell indirect
700,761
$6.75
$4.73M
Sean Bohen
11 Dec 2024
President and CEO
Sell
1,267
$9.39
$11.90K
Sean Bohen
11 Dec 2024
President and CEO
Sell
55,907
$8.66
$484.15K
Shane William Charles Kovacs
11 Dec 2024
Ch. Operating & Financial Off.
Sell
406
$9.39
$3.81K
Shane William Charles Kovacs
11 Dec 2024
Ch. Operating & Financial Off.
Sell
17,950
$8.66
$155.45K
Naseem Zojwalla
11 Dec 2024
Chief Medical Officer
Sell
320
$9.39
$3.00K
Naseem Zojwalla
11 Dec 2024
Chief Medical Officer
Sell
14,202
$8.66
$122.99K
David C. Myles
11 Dec 2024
Ch. Discov. & Non-Clin Dev Off
Sell
300
$9.39
$2.82K
David C. Myles
11 Dec 2024
Ch. Discov. & Non-Clin Dev Off
Sell
13,314
$8.66
$115.30K
Cyrus Harmon
11 Dec 2024
Director
Sell
179
$9.39
$1.68K
Cyrus Harmon
11 Dec 2024
Director
Sell
7,958
$8.66
$68.92K
Sean Bohen
10 Dec 2024
President and CEO
Sell
52,328
$9.37
$490.31K
Shane William Charles Kovacs
10 Dec 2024
Ch. Operating & Financial Off.
Sell
16,803
$9.37
$157.44K
Naseem Zojwalla
10 Dec 2024
Chief Medical Officer
Sell
13,283
$9.37
$124.46K
David C. Myles
10 Dec 2024
Ch. Discov. & Non-Clin Dev Off
Sell
12,452
$9.38
$116.80K
Cyrus Harmon
10 Dec 2024
Director
Sell
8,256
$9.37
$77.36K
Paradigm Biocapital Advisors LP
1 Aug 2024
10% owner
Sell indirect
529,501
$14.92
$7.90M
Paradigm Biocapital Advisors LP
1 Aug 2024
10% owner
Sell indirect
1,870,499
$14.92
$27.90M
G. Walmsley Graham
4 Jun 2024
Director
Sell indirect
475,000
$14.85
$7.05M
G. Walmsley Graham
4 Jun 2024
Director
Sell indirect
700,000
$14.85
$10.40M
Cyrus Harmon
29 Dec 2023
Director
Sell
2,500
$14.10
$35.25K
Cyrus Harmon
29 Dec 2023
Director
Sell
22,500
$13.30
$299.25K
Shane William Charles Kovacs
22 Nov 2023
Ch. Operating & Financial Off.
Sell
9,145
$13.89
$127.02K
Sean Bohen
22 Nov 2023
President and CEO
Sell
27,932
$13.90
$388.25K
David C. Myles
22 Nov 2023
Ch. Discov. & Non-Clin Dev Off
Sell
6,653
$13.89
$92.41K
Naseem Zojwalla
22 Nov 2023
Chief Medical Officer
Sell
7,095
$13.89
$98.55K
Cyrus Harmon
22 Nov 2023
Director
Sell
3,989
$13.90
$55.45K
Shane William Charles Kovacs
21 Nov 2023
Ch. Operating & Financial Off.
Sell
700
$15.27
$10.69K
Shane William Charles Kovacs
21 Nov 2023
Ch. Operating & Financial Off.
Sell
8,897
$14.83
$131.94K
Sean Bohen
21 Nov 2023
President and CEO
Sell
2,602
$15.29
$39.78K
Sean Bohen
21 Nov 2023
President and CEO
Sell
26,691
$14.84
$396.09K
David C. Myles
21 Nov 2023
Ch. Discov. & Non-Clin Dev Off
Sell
200
$15.32
$3.06K
David C. Myles
21 Nov 2023
Ch. Discov. & Non-Clin Dev Off
Sell
6,776
$14.87
$100.76K
Naseem Zojwalla
21 Nov 2023
Chief Medical Officer
Sell
200
$15.33
$3.07K
Naseem Zojwalla
21 Nov 2023
Chief Medical Officer
Sell
7,261
$14.83
$107.68K
Cyrus Harmon
21 Nov 2023
Director
Sell
4,192
$14.86
$62.29K
Cyrus Harmon
8 Jun 2023
Director
Sell
10,000
$6.30
$63.00K
Cyrus Harmon
6 Jun 2023
Director
Sell
5,000
$6.30
$31.48K
Cyrus Harmon
5 Jun 2023
Director
Sell
5,000
$6.05
$30.23K
David C. Myles
10 Dec 2021
Chief Development Officer
Sell
10,000
$10.30
$103.00K
Cyrus Harmon
29 Nov 2021
Chief Technology Officer
Sell
400
$24.76
$9.90K
Cyrus Harmon
19 Oct 2021
Chief Technology Officer
Sell
4,555
$28.20
$128.45K
Cyrus Harmon
19 Oct 2021
Chief Technology Officer
Sell
7,445
$27.85
$207.34K
Cyrus Harmon
20 Sep 2021
Chief Technology Officer
Sell
12,000
$26.30
$315.60K
Cyrus Harmon
19 Aug 2021
Chief Technology Officer
Sell
12,000
$24.97
$299.64K
Cyrus Harmon
20 Jul 2021
Chief Technology Officer
Sell
4,123
$25.63
$105.67K
Cyrus Harmon
19 Jul 2021
Chief Technology Officer
Sell
7,877
$24.83
$195.59K
Cyrus Harmon
18 Jun 2021
Chief Technology Officer
Sell
600
$26.30
$15.78K
Cyrus Harmon
18 Jun 2021
Chief Technology Officer
Sell
1,990
$25.59
$50.92K
Cyrus Harmon
18 Jun 2021
Chief Technology Officer
Sell
9,410
$24.54
$230.92K
Show all 162 transactions →

What was left out

Form 4 filings counted 203
Amendments (4/A) skipped 14
Filings about a different issuer 0
Unreadable filings 0
Joint filings 15
Sales on a Rule 10b5-1 plan 26
Sales straight out of an exercise 36
Sales at will 65
Transactions with no price 2
Shares from compensation/vesting 24,931,528
Sales filed before the plan box existed 11
History held since 19 Nov 2020